Hbk Investments L P Pfizer Inc Call Options Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $2.69 Million - $3.11 Million	-74,500 Reduced 88.8%	9,400 $344,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $3.3 Million - $4.3 Million	83,900 New	83,900 $3.42 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $7.13 Million - $8.71 Million	-163,000 Reduced 69.9%	70,200 $3.07 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $10.9 Million - $12.9 Million	233,200 New	233,200 $12.2 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.